Renaud Jardri Selected Research

Pharmaceutical Preparations

1/2022	Decoding Activity in Broca's Area Predicts the Occurrence of Auditory Hallucinations Across Subjects.
1/2022	From hallucinations to synaesthesia: A circular inference account of unimodal and multimodal erroneous percepts in clinical and drug-induced psychosis.
12/2020	Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison.
1/2018	Prediction of activation patterns preceding hallucinations in patients with schizophrenia using machine learning with structured sparsity.
5/2013	The neurodynamic organization of modality-dependent hallucinations.
1/2009	Clinical practice of rTMS reveals a functional dissociation between agency and hallucinations in schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renaud Jardri Research Topics

Disease

17	Hallucinations (Hallucination) 01/2022 - 01/2009
8	Schizophrenia (Dementia Praecox) 01/2022 - 01/2008
3	Cognitive Dysfunction 01/2022 - 12/2017
2	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 05/2013
2	Catatonia 10/2021 - 11/2018
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Neurobehavioral Manifestations 12/2021
1	Mood Disorders (Mood Disorder) 06/2019
1	Major Depressive Disorder (Major Depressive Disorders) 06/2019
1	Seizures (Absence Seizure) 11/2018
1	Psychomotor Agitation (Akathisia) 11/2018
1	Alcoholism (Alcohol Abuse) 02/2017
1	Neonatal Abstinence Syndrome 01/2016
1	Inflammation (Inflammations) 06/2013
1	Dystonia (Limb Dystonia) 01/2009

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2022 - 01/2009
5	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2009
3	Hallucinogens (Psychedelics)IBA 01/2022 - 01/2014
2	salicylhydroxamic acid (SHAM)IBA 12/2021 - 03/2016
2	Biological ProductsIBA 12/2021 - 10/2021
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016 - 01/2014
1	Aripiprazole (Abilify)FDA Link 01/2022
1	Clozapine (Clozaril)FDA LinkGeneric 01/2022
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 10/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021
1	Rituximab (Mabthera)FDA Link 10/2021
1	Antidepressive Agents (Antidepressants)IBA 06/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Lorazepam (Ativan)FDA LinkGeneric 11/2018
1	Vigabatrin FDA Link 11/2018
1	SolutionsIBA 01/2018
1	Baclofen FDA LinkGeneric 02/2017
1	nasIBA 01/2016
1	gamma-Aminobutyric Acid (GABA)IBA 01/2016
1	tianeptine (Stablon)IBA 01/2016
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2014
1	Glutamic Acid (Glutamate)FDA Link 01/2014
1	Serotonin (5 Hydroxytryptamine)IBA 01/2014
1	Dissociative AnestheticsIBA 01/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2013
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2013
1	LipidsIBA 06/2013
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2008

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2016
4	Transcranial Magnetic Stimulation 06/2019 - 04/2010
3	Neurofeedback 12/2020 - 01/2016
2	Transcranial Direct Current Stimulation 12/2021 - 03/2016
1	Immunotherapy 10/2021
1	Plasma Exchange 10/2021
1	Bathroom Equipment 11/2018
1	Institutionalization (Institutionalized Persons) 12/2017
1	Electrodes (Electrode) 03/2016